{
Lonza Group AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-262025-03-261111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-262025-03-261111100
Download SVG
Download PNG
Download CSV

high potency active pharmaceutical ingredients market trends and future growth prospects

The High Potency Active Pharmaceutical Ingredients Market is experiencing significant growth, driven by increased demand, technological advancements, and a broadening customer base. A comprehensive report provides insights into market trends, competitive landscape, and future opportunities, highlighting key players such as Lonza and Novartis. The analysis covers various segments, production technologies, and applications, offering a detailed outlook on the industry's trajectory through 2032.
openPR.com
Merck & Co., Inc. Roche Diagnostics AG Eli Lilly and Company Teva Pharmaceutical Industries Ltd BASF AG Novartis International AG Lonza Group AG Bristol-Myers Squibb Co Cambrex Corporation Seqens Pfizer Inc. Sanofi Aventis SA Bayer AG CARBOGEN AMCIS AG Alice Mutum Viju Shah Show more
Business & Industry, Market Report
10:02 26.03.2025

cell line development market projected to grow at 12.13 percent CAGR through 2031

The global Cell Line Development Market is projected to grow at a CAGR of 12.13% from 2024 to 2031, driven by increasing demand in drug discovery and biopharmaceutical production. Key players include Lonza Group AG, Thermo Fisher Scientific Inc, and GE Healthcare, with significant regional markets in North America, Europe, and Asia-Pacific. The report offers insights into market trends, challenges, and opportunities, utilizing both qualitative and quantitative research methods.
openPR.com
Euro United States Dollar Thermo Fisher Scientific Inc. Promega Corporation Corp. Lonza Group AG Corning Inc GE HealthCare Technologies Inc. NLD FRA ESP MEX GBR ARE ITA IND JPN CAN AUS RUS DEU ZAF KOR SAU BRA USA CHN IDN COL ARG Saikiran Show more
Healthcare & Medicine, Market Report
19:14 22.03.2025

Swiss stock market edges up as Oerlikon and Basilea report strong results

The Swiss stock market closed slightly higher, with the SMI rising 0.15% to 12,893.98 points, buoyed by gains in cyclical and financial stocks. Notable performers included OC Oerlikon (+8.7%) and Basilea (+8.3%), while Lonza (-2.7%) and Siegfried (-6.3%) faced declines due to conservative outlooks. Encouraging economic signals from Germany and the USA contributed to a positive market sentiment.
Finanz und Wirtschaft
United States Dollar Euro Swiss Franc Straumann Holding AG Roche Holding AG Lonza Group AG ABB Ltd Sandoz Group AG Julius Bär Gruppe AG Alstom SA Novartis AG Swiss Re AG Nestlé S.A. Zurich, Agence générale Christian Meier SA OC Oerlikon Corp AG, Pfaffikon DEU USA CHE Show more
Finance & Economy, Market Report
08:06 18.02.2025

Swiss stock market gains momentum led by UBS and Holcim shares

Swiss equities showed slight gains, with the SMI rising 0.4% to 12,624 points, supported by strong performances from Holcim (+3.7%) and UBS (+3.6%). Optimism among Swiss entrepreneurs and a positive impulse from the Bank of England contributed to the market's mood, despite losses in major pharmaceutical stocks Roche (-1.2%) and Novartis (-0.9%).
MarketScreener
United States Dollar Swiss Franc Holcim AG Sika AG Lonza Group AG Zurich Insurance Group AG Sonova R Novartis AG Hoffmann-La Roche AG CHE Show more
Finance & Economy, Market Report
17:54 06.02.2025

swiss equities decline as UBS shares slump amid financial market uncertainty

Swiss equities faced a downturn, with the SMI index dropping 0.57% to 12,475.49 points, primarily due to a 7.1% decline in UBS shares amid capital concerns despite positive results. The market remains volatile, influenced by ongoing tariff disputes, particularly with China. Notable losers included Swatch (-3.2%) and Sonova (-3.4%), while Medacta stood out with an 11% gain following strong sales figures.
MarketScreener
Swiss Franc Sonova R Logitech International S.A. PolyPeptide Group AG ABB Ltd Galderma Group N Julius Bär Gruppe AG Zurich, Agence générale Christian Meier SA DSV AS Lonza Group AG Medacta Group SA Novartis AG Nestlé S.A. Hoffmann-La Roche AG CHE Francesco Siccardi Show more
Finance & Economy, Market Report
18:16 04.02.2025

swiss stock market declines amid escalating trade war tensions

The Swiss stock market is under pressure due to escalating trade tensions following the US tariffs on imports from China, Canada, and Mexico. The Swiss Market Index (SMI) fell 0.61%, with only six of the thirty leading stocks gaining, while UBS saw a significant drop of 5.8% amid profit-taking. Analysts warn of potential broader customs barriers as China retaliates with its own tariffs and a complaint to the WTO.
agefi.com
Chinese Yuan United States Dollar Straumann Holding AG RICHEMONT, Intellectual Property Services Lonza Group AG Novartis AG Nestlé S.A. Hoffmann-La Roche AG Sandoz Group AG USA DEU MEX CHN CAN John Plassard Ipek Ozkardeskaya Show more
Finance & Economy, Market Report
11:37 04.02.2025

swiss stock market declines amid rising global trade tensions and tariffs

The Swiss stock market opened lower amid rising global protectionism, influenced by new US tariffs on imports from China, Canada, and Mexico. The Swiss Market Index fell 0.85%, with only four of the thirty leading stocks gaining, including Lonza and Novartis. Analysts note that the escalating trade war is affecting Europe as well, highlighting the complexities of international trade relations.
agefi.com
Chinese Yuan United States Dollar Novartis AG Lonza Group AG Sandoz Group AG Zurich Insurance Group AG USA DEU MEX CHN CAN John Plassard Ipek Ozkardeskaya Show more
Finance & Economy, Market Report
10:21 04.02.2025

Swiss stock market declines as UBS and Sonova shares fall sharply

The Swiss stock market faced a downturn, with the SMI index dropping below 12,500, primarily due to a significant decline in UBS shares amid capital concerns. While some companies like Lonza and Medacta saw gains, others, including Swatch and Sonova, struggled as uncertainty from international tariff disputes continued to weigh on investor sentiment.
Finanz und Wirtschaft
Swiss Franc Sonova R Logitech International S.A. PolyPeptide Group AG Novartis AG Galderma Group N ABB Ltd Julius Bär Gruppe AG Zurich, Agence générale Christian Meier SA Lonza Group AG Medacta Group SA The Swatch Group AG Nestlé S.A. Hoffmann-La Roche AG CHE Francesco Siccardi Show more
Finance & Economy, Market Report
05:52 04.02.2025

global markets decline as trump tariffs raise economic concerns

The Swiss stock market closed lower, with the SMI down 0.40% amid global concerns over Donald Trump's new tariffs on key trading partners, which investors fear could harm the economy. While the services sector in Switzerland showed growth, manufacturing faced significant challenges, leading to workforce cuts. Notable stock movements included Julius Bär dropping 12.7% and Lonza rising 2.7%.
agefi.com
Swiss Franc Euro United States Dollar Chinese Yuan Singapore Dollar Logitech International S.A. Novartis AG ABB Ltd Sika AG RICHEMONT, Intellectual Property Services Lonza Group AG The Swatch Group AG Nestlé S.A. Hoffmann-La Roche AG Sandoz Group AG USA CHN CHE CAN Francisco Ballester John Plassard Peter Stenico Show more
Finance & Economy, Market Report
18:01 03.02.2025

trump returns to office as earnings season begins with strong netflix results

Donald Trump has returned to the White House, marking the start of his second term amid a bustling earnings season. Netflix led the charge with impressive fourth-quarter results, reporting a surge in subscribers and a net income of $1.87 billion, while major companies like Microsoft and Apple are set to release their figures next week. Despite some market volatility, U.S. indices remain near all-time highs as investors navigate the implications of Trump's pro-business agenda and potential trade policies.
Place à la seconde investiture de Trump, alors que la saison des résultats bat son plein. Le commentaire boursier de la BCVs
United States Dollar Logitech International S.A. AMD/BRX Novartis AG Netflix, Inc. Tesla, Inc. Apple Inc. Microsoft Corporation Lonza Group AG Hoffmann-La Roche AG Adobe Inc. USA MEX CHE CAN Donald Trump Martin Luther King Jr. Show more
Finance & Economy, Market Report
12:00 27.01.2025
Trending
Subcategory
Corporate News Stock Market Updates Industry Trends Banking Regulations Global Financial Events Retail and Consumer Goods Finance Mergers & Acquisitions Industry Mergers & Acquisitions CEO Changes Workplace Trends Central Bank Actions Global Trade Developments Market Analysis and Predictions Financial Scams and Security GDP Growth & Recession Forecasts Government Policies Inflation and Monetary Impact Government Economic Policies Supply Chain Management Startups & Entrepreneurship
Countries:
USA CHN CHE GBR DEU FRA ITA CAN IND JPN MEX ESP HKG AUS ARE DNK NLD RUS BRA IRL
Companies:
JPMorgan Chase & Co. The Goldman Sachs Group, Inc. Tesla, Inc. Barclays PLC Apple Inc. Deutsche Bank Money Market PP Credit Suisse Lux Digital Healt Bank of America Corporation Wells Fargo & Company Citigroup Inc. BNP Paribas SA Banco Santander, S.A. UBS Group AG Morgan Stanley Commerzbank AG UniCredit S.p.A. Lloyds Banking Group plc Huawei Technologies CO. Ltd. SpaceXCoin USD Berkshire Hathaway Inc.
Currencies:
United States Dollar Euro British Pound Sterling Chinese Yuan Swiss Franc Japanese Yen Indian Rupee Australian Dollar Russian Ruble Danish Krone Canadian Dollar Mexican Peso United Arab Emirates Dirham Offshore Chinese Yuan Hong Kong Dollar Indonesian Rupiah Saudi Riyal South Korean Won Turkish Lira Malaysian Ringgit
People:
Donald Trump Elon Musk Warren Buffett Joe Biden Robin Leopold Christian Sewing Goldman Sachs Brad Schimel Troy L Rohrbaugh Solita Marcelli Stacey Friedman Sabrina Meng Bruno Marxer Will Hardcastle Susan P. Crawford Meng Wanzhou Ulrike Hoffmann-Burchardi Jerome Powell Kirsty Roth Klaus Moosmayer

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.